Substituted diazepan compounds as orexin receptor antagonists
Details for Australian Patent Application No. 2007328267 (hide)
International Classifications
Event Publications
11 June 2009 PCT application entered the National Phase
PCT publication WO2008/069997 Priority application(s): WO2008/069997
21 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
24 March 2011 Application Accepted
Published as AU-B-2007328267
21 July 2011 Standard Patent Sealed
11 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007328280-Hydroxylamine derivatives for the treatment of stroke
2007328265-A composition for treatment of connective tissues
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser